ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 374 filers reported holding ASTRAZENECA PLC in Q1 2014. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,648,975 | -1.8% | 24,350 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $1,680,034 | +104.9% | 23,474 | -13.6% | 0.00% | 0.0% |
| Q2 2016 | $820,000 | +6.1% | 27,160 | -1.1% | 0.00% | 0.0% |
| Q1 2016 | $773,000 | -17.1% | 27,460 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $932,000 | +12.4% | 27,460 | +5.4% | 0.00% | 0.0% |
| Q3 2015 | $829,000 | -0.1% | 26,060 | +100.0% | 0.00% | 0.0% |
| Q2 2015 | $830,000 | -25.3% | 13,030 | -19.7% | 0.00% | 0.0% |
| Q1 2015 | $1,111,000 | -10.5% | 16,230 | -7.9% | 0.00% | -25.0% |
| Q4 2014 | $1,241,000 | -1.4% | 17,630 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,259,000 | -6.5% | 17,630 | -2.8% | 0.00% | 0.0% |
| Q2 2014 | $1,347,000 | +18.5% | 18,130 | +3.4% | 0.00% | +33.3% |
| Q1 2014 | $1,137,000 | +8.6% | 17,530 | -0.6% | 0.00% | 0.0% |
| Q4 2013 | $1,047,000 | +141.8% | 17,630 | +111.6% | 0.00% | +200.0% |
| Q3 2013 | $433,000 | +68.5% | 8,330 | +53.4% | 0.00% | 0.0% |
| Q2 2013 | $257,000 | – | 5,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |